由买买提看人间百态

boards

本页内容为未名空间相应帖子的节选和存档,一周内的贴子最多显示50字,超过一周显示500字 访问原贴
Biology版 - SABPA BioPharma Conference June 8 (转载)
相关主题
[Early Birds End On May 22] SABPA BioPharma Conference on J (转载)新年随笔-3 (转载)
9th Annual SABPA Pacific Forum Oct. 5 (转载)Paper Help
第13届圣地亚哥生物医药年会 - 6月21日美国哪个州生物制药公司多?
请问做蛋白和生物工程谁更容易找industry的工作?China's $300 billion goal
文献求助!麻烦不断啊
为兴趣而工作的日子终于来临!借宝地问一下做endocytosis方面的大牛
生物技术vs生物制药job内推LC-MS相关职位 (转载)
在中国START-UP生物技术公司的可行性第二届宁波“3315计划”生命健康专业海外(圣地亚哥)创业创新大赛
相关话题的讨论汇总
话题: san话题: diego话题: ceo话题: sabpa话题: june
进入Biology版参与讨论
1 (共1页)
S***A
发帖数: 40
1
【 以下文字转载自 SanDiego 讨论区 】
发信人: SABPA (美中生物技术与医药协会), 信区: SanDiego
标 题: SABPA BioPharma Conference June 8
发信站: BBS 未名空间站 (Fri May 31 02:16:38 2013, 美东)
Date: June 8th, 2013, 8:00am – 4:45pm
Location: Hilton, San Diego/Del Mar
Directions: Go to the bottom of page
Registration: https://www.123signup.com/register?id=bdkys
$30 for early birds (by June 2), $50 before end of June 5, $80 for onsite
registration, students and postdocs $10 off (The fees include parking at the
hotel, program brochure, continental breakfast, coffee break, and lunch).
Online registration closes on June 2.
Organizer: Sino-American Biomedical & Pharmaceutical Professionals
Association (SABPA)
Co-organizer: SDCAA, ACS, UCSD
Sino-American Biotechnology and Pharmaceutical Professionals Association (
SABPA) is a local non-profit professional organization http://www.sabpa.org. At this year’s San Diego Bio-Pharma Conference, we bring together top-notched speakers to discuss recent breakthroughs in life science and latest industry trends on a global scale. We are also putting together a very rare and exciting drug discovery panel representing elite local companies with drugs that have recently gained FDA approvals to showcase San Diego’s drug discovery success stories. The program is guaranteed to generate sizzling discussion and stimulate new ideas with renewed enthusiasm of investing in San Diego biotech.
Program
8:00 am Exhibition (all day)
8:00 am Continental Breakfast & Registration
8:45 am Opening Remarks
Mingzhu Zhang, President, SABPA San Diego
Mao Mao, Research Fellow, Pfizer, Inc
9:00 am Keynote Speech: Personalized Medicine in Complex Human Disease: A
Cautionary Tale
Gary S. Firestein, M.D., Director, Clinical and Translational Research
Institute.
The Dean and Associate Vice Chancellor, Translational Medicine, UC San Diego
9:40 am Session I. Drug Discovery in the Post-Genomic Era
Session Chair: Wendy Wang, Sr. Engineer, Genoptix
Title: Innovating in Peptide and Protein Therapeutic Space: Recent Progress
and Future
Prospects
Keith James, Ph.D., President, Ferring Research Institute.
Sr. VP, R&D, Ferring Pharmaceuticals
Title: Maximizing Success of Drug development by Optimal Patient
Stratification
Shabnam Tangri, Ph.D., Executive Director, Genoptix.
Head, Clinical Trial Center of Exellence, Genoptix
10:40 am Coffee Break
11:00 am Session II (Plenary Discussion): Made in San Diego
Moderator: Jonathan Lim, M.D., CEO, Ignyta; Managing Partner, City Hill
Ventures
Jean Cui, Ph.D., Associate Research Fellow, Pfizer Inc.
Jack Lief, CEO, Arena Pharmaceuticals Inc.
Larry Z. Shen, Ph.D., VP, Corporate Analytics, Amylin Pharmaceuticals, LLC,
a Bristol-Myers Squibb Company
Wendell Wierenga, Ph.D., Executive Vice President, R&D, Santarus
Ashley Van Zeelan, Ph.D., Co-Founder and CEO, Cypher Genomics
12:00 am Luncheon
1:30 pm San Diego Bio-Pharma Achievement Award
Moderator: Ming Guo, Vice President, Ascentage Pharma
Award Recipients: Jack Lief, CEO, Arena Pharmaceuticals
1:40 pm Session III: Charting a New Course for Innovations
Session Chair: JC Xu, Director, Biology, Quanticel Pharmaceuticals
1:45 pm Title: Creating a Successful Biotech Company … a Work in
Progress
Jack Lief, Ph.D., CEO of Arena Pharmaceuticals Inc.
2:15pm Title: CTI: A New Model for Accelerating Translation of Basic
Academic Science to the
Clinic
Richard A. Lindberg, Ph.D., Executive Director and Head of the Centers for
Therapeutic Innovation-
California, Pfizer
Title: Life Sciences VC Financing in China & India
Justin Chakma, B.Sc., Analyst, Thomas, McNerny & Partners
3:10 pm Coffee Break
3:30 pm Session IV Plenary Discussion: Innovations in China
Moderator: Xiao Xu, President, ACEA Biosciences Inc.
Shiang Huang, M.D., Founder and CEO, Kindstar Global
Youling Wu, Ph.D., CEO, Teruisi Pharmaceutical Inc.
Tracy T. Yeo, Ph.D., Director, Consulting at ChinaBio, LLC
Xiaokun Zhang, Ph.D., Professor and Dean, Institute of Biomedical Research,
Xiamen
University; Professor, Sanford-Burnham Medical Research Institute, USA
4:45 pm Closing Remark
Hui Li, Ph.D., Chair, Board of Directors, SABPA
1 (共1页)
进入Biology版参与讨论
相关主题
第二届宁波“3315计划”生命健康专业海外(圣地亚哥)创业创新大赛文献求助!
国内生物制药工艺副总监为兴趣而工作的日子终于来临!
Contractor position in immuno-oncology生物技术vs生物制药job
Sales Manager - Western Region在中国START-UP生物技术公司的可行性
[Early Birds End On May 22] SABPA BioPharma Conference on J (转载)新年随笔-3 (转载)
9th Annual SABPA Pacific Forum Oct. 5 (转载)Paper Help
第13届圣地亚哥生物医药年会 - 6月21日美国哪个州生物制药公司多?
请问做蛋白和生物工程谁更容易找industry的工作?China's $300 billion goal
相关话题的讨论汇总
话题: san话题: diego话题: ceo话题: sabpa话题: june